Posts Tagged ‘Enterprise’

Breast Cancer Market ? An Analysis – Market Research Report on Aarkstore Enterprise

Breast cancer is the second most common type of cancer after lung cancer worldwide and the fifth most common cause of cancer death. It is found more in women as compared to men. Worldwide more than one million new cases of breast cancer are found every year. New breast cancer cases are mostly found in North America.

Breast cancer is usually found in women over the age of 40 years. Breast cancer cases have risen about 30% in the past 25 years in western countries like the US and Europe. Breast cancer market is comprised of two segments – diagnostic and therapy. The key drivers of breast cancer market are aging population, obesity and family history among others.

The stages of breast cancer are of critical importance and decide the treatment method and the extent to which it can be cured. Mammography is believed to find 85% to 90% of breast cancers in women over 50, and can discover a lesion one to four years before a lump can be felt. In case of patients with dense breast tissue, breast implants or patients who are breastfeeding, mammography cannot produce clear images and therefore, in such cases, ultrasound or MRI is recommended. Biopsy is used for the diagnosis of breast cancer once a lesion is detected in screening. For treatment of breast cancer, surgery is used first and then drugs or radiation therapy or both are used.

The major players of breast cancer market are strengthening their networks through international alliances, agreements, strategic acquisitions, exploring new markets and R&D initiatives that will help in more effective diagnosis and treatment of breast cancer.

This report provides an overview of the breast cancer, its types and stages, and incidence rates. The markets for diagnosis and treatment of breast cancer have been analyzed. Markets for diagnosis and treatment like, mammography, biopsy, chemotherapy, radiotherapy and drugs have also been discussed. The report also analyzes the drivers, issues and trends in the breast care market. The major players in the market are profiled along with their key business strategies.

Table of Contents :

1. Breast Cancer Types and Stages

Types of breast cancer
Stages of breast cancer
Survival rates at different stages of breast cancer

2. Breast Cancer Market Overview

Deaths in males/females by age group and region
New breast cancer cases in different regions of the world
US breast cancer incidence/death rates by race/color
Causes of cancer

2.1 Breast Cancer Screening, Diagnosis and Treatment

Screening, diagnosis and treatment processes
Use of drugs and therapies in treatment of breast cancer

3. Screening/Diagnostics Market

3.1 Mammography

Global mammography market and its segments
Share of different regional markets in mammography
Drivers of mammography market
Competition in the global mammography equipment market
North American mammography market and market share of main players
Role of MRIs and ultrasound

3.2 Blood-based Diagnostic Test

Blood based breast cancer diagnostic tests
Potential market in India and the UK

3.3 Biopsy Market

Global breast biopsy market size and growth
Market share of main players in the global breast biopsy market
Various breast biopsy methods

4. Breast Cancer Treatment Market

4.1 Therapy Market

Use of therapies at different stages of breast cancer

4.1.1 Radiotherapy Market

Market share of main players in radiation therapy market

4.1.2 Chemotherapy and Taxane Drugs Market

Global Taxane drug market size
Abraxane drug market size and forecast
Abraxane market share in the US

5. Market Movements

5.1 Growth drivers

5.1.1 Aging Population
5.1.2 Family history of breast cancer
5.1.3 Hormonal factors
5.1.4 High breast tissue density
5.1.5 Obesity

5.2 Key Issues

5.2.1 Mammogram radiation raises breast cancer risk in women
5.2.2 Lack of health insurers

5.3 Breast Care Market Trends

5.3.1 Advances in Imaging Technology for Screening
5.3.2 Advances in Imaging Technology for Biopsy
5.3.3 Paradigm Shift to Less Invasive Procedures
5.3.4 Emergence of Integrated Breast Centers

6. Company Profiles

6.1 Hologic Inc.

Business Overview
Business Strategies
Expanding through acquisitions
Introducing 3D digital technology

6.2 SenoRx, Inc

Business Overview
Business Strategies
Provide Differentiated, Tailored Solutions in the Breast Biopsy Market
Leveraging R&D Competencies
Pursue Strategic Acquisitions and Partnerships

6.3 Johnson and Johnson

Business Overview
Business Strategies
Acquisitions to strengthen business
Creating franchises in Pharmaceutical business

6.4 Siemens AG

Business Overview
Business Strategies
Company reorganization
Improving Healthcare worldwide

7. Metastatic Breast Cancer Forecast

For more information, please visit :

http://www.aarkstore.com/reports/Breast-Cancer-Market-An-Analysis-36164.html

Breast Cancer – Drug Pipeline Analysis and Market Forecasts to 2016-Aarkstore Enterprise

The industry analysis specialist’s new report, “Breast Cancer – Drug Pipeline Analysis and Market Forecasts to 2016″ is an essential source of information and analysis on the global breast cancer market,a key segment within the pharmaceutical and healthcare industry. The report identifies the key trends shaping and driving the global breast cancer market, within the oncology sector. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global breast cancer sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData’s team of industry experts.

Scope

The scope of the report includes:
- Annualized global breast cancer market revenues data from 2000 to 2009, forecast forward for 7 years to 2016.
- Geographic markets covered in this report include the US (United States), the UK (United Kingdom), Italy, Spain, Germany, France, and Japan.
- Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends.
- Analysis of the current and future market competition in the global breast cancer market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with breast cancer. Key market players discussed include Bipar Sciences Inc, Biomira USA Inc, Apthera Inc, Novartis AG, OncoGenex Pharmaceuticals, Amgen, Johnson & Johnson, Schering-Plough and AstraZeneca.

Reasons to buy

The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
- Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global breast cancer market.
- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global breast cancer market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global breast cancer market landscape? – Identify, understand and capitalize.” $2,000 $4,000 $6,000 GDHCPRT032 Pharmaceuticals and Healthcare Market forecast, revenues, unmet need, drivers, barriers, pharma, clinical trials, marketed products, pipeline, promising drugs, future players, key companies, strategic competitor assessment, market characterization, implications for future market, mechanism of action. 
 

For more information,please visit:

http://www.aarkstore.com/reports/Breast-Cancer-Drug-Pipeline-Analysis-and-Market-Forecasts-to-2016-40618.html

Breast Cancer Therapy Area Pipeline Report–Aarkstore Enterprise

Breast Cancer Therapy Area Pipeline Report contains detailed information on the breast cancer drug pipeline. This report provides insight into the pipeline status of breast cancer drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.

In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company’s full product pipeline and products by phase of development with regard to the therapy area.

Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.

Key benefits

• Understand a company’s strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
• Keep track of your competitors and partners by better understanding their product pipeline.
• Monitor a company’s research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
• Maintain a critical competitive advantage.

For more information, please visit :

http://www.aarkstore.com/reports/Breast-Cancer-Therapy-Area-Pipeline-Report-14220.html

Or email us at press@aarkstore.com or call +919272852585

New Report “breast Cancer Market – An Analysis” Available Through Aarkstore Enterprise

Breast cancer is the second most common type of cancer after lung cancer worldwide and the fifth most common cause of cancer death. It is found more in women as compared to men. Worldwide more than one million new cases of breast cancer are found every year. New breast cancer cases are mostly found in North America.

Breast cancer is usually found in women over the age of 40 years. Breast cancer cases have risen about 30% in the past 25 years in western countries like the US and Europe. Breast cancer market is comprised of two segments – diagnostic and therapy. The key drivers of breast cancer market are aging population, obesity and family history among others.

The stages of breast cancer are of critical importance and decide the treatment method and the extent to which it can be cured. Mammography is believed to find 85% to 90% of breast cancers in women over 50, and can discover a lesion one to four years before a lump can be felt. In case of patients with dense breast tissue, breast implants or patients who are breastfeeding, mammography cannot produce clear images and therefore, in such cases, ultrasound or MRI is recommended. Biopsy is used for the diagnosis of breast cancer once a lesion is detected in screening. For treatment of breast cancer, surgery is used first and then drugs or radiation therapy or both are used.

The major players of breast cancer market are strengthening their networks through international alliances, agreements, strategic acquisitions, exploring new markets and R&D initiatives that will help in more effective diagnosis and treatment of breast cancer.

This report provides an overview of the breast cancer, its types and stages, and incidence rates. The markets for diagnosis and treatment of breast cancer have been analyzed. Markets for diagnosis and treatment like, mammography, biopsy, chemotherapy, radiotherapy and drugs have also been discussed. The report also analyzes the drivers, issues and trends in the breast care market. The major players in the market are profiled along with their key business strategies.

For more information, please visit :
http://www.aarkstore.com/reports/Breast-Cancer-Market-An-Analysis-36164.html
Or email us at press@aarkstore.com or call +919272852585